Ling-Ling Chang (Lingling Chang)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Acute Myocardial Infarction

Signaling Pathway

Top Venues

Oxidative medicine and cellular longevity

Pharmaceutical biology

Fudan University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Fudan University Sep 1o 2014

China

PHD :: school of pharmacy

Publications

Beilei Ma, Yi-Cheng Mao, Ling-Ling Chang, Tao Dai, Xiaoming Xin, Fenfen Ma, Zhijun Wang, Zhuqing Shen, Qibing Mei, Qiu-Yan Zhang
S -Propargyl-cysteine prevents concanavalin A-induced immunological liver injury in mice. Pharmaceutical biology 60 (1) (2022)
Qiu-Yan Zhang, Zhi-Jun Wang, Lei Miao, Ying Wang, Ling-Ling Chang, Wei Guo, Yi Zhun Zhu
Neuroprotective Effect of SCM-198 through Stabilizing Endothelial Cell Function. Oxidative medicine and cellular longevity 2019 (2019)
Ling-Ling Chang, Zhi-Jun Wang, Fenfen Ma, Bahieu Tran, Rui Zhong, Ying Xiong, Tao Dai, Jian Wu, Xiaoming Xin, Wei Guo, Ying Xie, Yi-Cheng Mao, Yi Zhun Zhu
ZYZ-803 Mitigates Endoplasmic Reticulum Stress-Related Necroptosis after Acute Myocardial Infarction through Downregulating the RIP3-CaMKII Signaling Pathway. Oxidative medicine and cellular longevity 2019 (2019)